Kimia Biosciences Ltd vs Sudeep Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Kimia Biosciences Ltd is ₹ 35.21 as of 30 Apr 15:30 . The P/E Ratio of Kimia Biosciences Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Sudeep Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of Kimia Biosciences Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Sudeep Pharma Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The revenue of Kimia Biosciences Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sudeep Pharma Ltd for the Dec '25 is ₹ 179.17 crore as compare to the Sep '25 revenue of ₹ 172.83 crore. This represent the growth of 3.67% The ebitda of Kimia Biosciences Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sudeep Pharma Ltd for the Dec '25 is ₹ 66.81 crore as compare to the Sep '25 ebitda of ₹ 65.63 crore. This represent the growth of 1.8% The net profit of Kimia Biosciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Sudeep Pharma Ltd changed from ₹ 17.08 crore to ₹ 47.7 crore over 7 quarters. This represents a CAGR of 79.84% The Dividend Payout of Kimia Biosciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sudeep Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Kimia Biosciences Ltd

Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal.
The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana.
The Company is engaged into the business of Pharamaceutical products. The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr.
It came out with a public issue in Feb.'95 to part-finance the project.
Commercial production commenced in May '95. During the 1998-99, the company has become a sick industrial units. The Hon'ble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turning-out to be an ancillary industrial Undertaking.

About Sudeep Pharma Ltd

Sudeep Pharma Limited was incorporated as Sudeep Pharma Private Limited' as a private limited company dated December 21, 1989, issued by the Registrar of Companies, Ahmedabad.
Thereafter, Company was converted into a public limited company and the name of the Company was changed to Sudeep Pharma Limited' pursuant to fresh certificate of incorporation dated April 5, 1995, issued by the Assistant Registrar of Companies, Gujarat at Dadra & Nagar Haveli.
Company was subsequently converted back to a private limited company vide a fresh certificate of incorporation dated October 1, 2014 issued by the Assistant Registrar of Companies, Gujarat at Ahmedabad, and the name of Company was accordingly changed from Sudeep Pharma Limited' to Sudeep Pharma Private Limited'.
Further, Company was converted into a public limited company and consequently, the name of Company was changed to Sudeep Pharma Limited'.

FAQs for the comparison of Kimia Biosciences Ltd and Sudeep Pharma Ltd

Which company has a larger market capitalization, Kimia Biosciences Ltd or Sudeep Pharma Ltd?

Market cap of Kimia Biosciences Ltd is 166 Cr while Market cap of Sudeep Pharma Ltd is 7,997 Cr

What are the key factors driving the stock performance of Kimia Biosciences Ltd and Sudeep Pharma Ltd?

The stock performance of Kimia Biosciences Ltd and Sudeep Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kimia Biosciences Ltd and Sudeep Pharma Ltd?

As of May 3, 2026, the Kimia Biosciences Ltd stock price is INR ₹35.21. On the other hand, Sudeep Pharma Ltd stock price is INR ₹708.1.

How do dividend payouts of Kimia Biosciences Ltd and Sudeep Pharma Ltd compare?

To compare the dividend payouts of Kimia Biosciences Ltd and Sudeep Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.